Stephen-Johnson syndrome (SJS) is a rare and life-threatening autoimmune disorder that affects the skin and mucous membranes. It is characterized by a sudden onset of severe blistering, which can lead to widespread skin loss and potentially life-threatening complications.
The condition is often misdiagnosed or mistaken for other conditions such as Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), or even burns. It's essential to seek immediate medical attention if you experience any symptoms of SJS, as prompt treatment can significantly improve outcomes.
While the exact cause of SJS is still unknown, it's believed to be triggered by an immune response to a medication or infection. Certain medications, such as antibiotics and anticonvulsants, have been linked to increased risk of developing SJS.
Other factors that may increase your risk include having a weakened immune system, being under 20 years old, or having a history of skin conditions like eczema or psoriasis.
The primary goal of treatment is to manage symptoms, reduce inflammation, and prevent further skin damage. This may involve the use of corticosteroids, immunoglobulin therapy, or other medications.
In severe cases, hospitalization may be necessary to provide supportive care, such as fluid replacement and pain management. It's crucial to work closely with your healthcare provider to develop a personalized treatment plan.